PRMT5 inhibition by JNJ-64619178 led to a significantly smaller number of colonies compared to vehicle (DMSO) treated groups in all the cancer cell lines (Figure 5), which indicates that JNJ-64619178 is successfully rendering the cancer cells sensitive to IR treatment. This evidence concerns the gene PRMT5 and cancer.